• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 在动脉粥样硬化和再狭窄中的作用。

Roles of microRNAs in atherosclerosis and restenosis.

机构信息

Division of Medical Engineering Research, National Health Research Institutes, Miaoli 350, Taiwan.

出版信息

J Biomed Sci. 2012 Aug 29;19(1):79. doi: 10.1186/1423-0127-19-79.

DOI:10.1186/1423-0127-19-79
PMID:22931291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3438039/
Abstract

Atherosclerosis is commonly appreciated to represent a chronic inflammatory response of the vascular wall, and its complications cause high mortality in patients. Angioplasty with stent replacement is commonly performed in patients with atherosclerotic disease. However, the restenosis usually has a high incidence rate in angioplasty patients. Although the pathophysiological mechanisms underlying atherosclerosis and restenosis have been well established, new signaling molecules that control the progress of these pathologies have continuously been discovered. MicroRNAs (miRs) have recently emerged as a novel class of gene regulators that work via transcriptional degradation and translational inhibition or activation. Over 30% of genes in the cell can be directly regulated by miRs. Thus, miRs are recognized as crucial regulators in normal development, physiology and pathogenesis. Alterations of miR expression profiles have been revealed in diverse vascular diseases. A variety of functions of vascular cells, such as cell differentiation, contraction, migration, proliferation and inflammation that are involved in angiogenesis, neointimal formation and lipid metabolism underlying various vascular diseases, have been found to be regulated by miRs. This review summarizes current research progress and knowledge on the roles of miRs in regulating vascular cell function in atherosclerosis and restenosis. These discoveries are expected to present opportunities for clinical diagnostic and therapeutic approaches in vascular diseases resulting from atherosclerosis and restenosis.

摘要

动脉粥样硬化通常被认为代表血管壁的慢性炎症反应,其并发症导致患者死亡率高。血管成形术伴支架置换术常用于动脉粥样硬化疾病患者。然而,血管成形术后再狭窄的发生率通常很高。尽管动脉粥样硬化和再狭窄的病理生理机制已经得到很好的确立,但控制这些病理进展的新信号分子不断被发现。微小 RNA(miRs)最近被认为是一类新型的基因调控因子,通过转录降解和翻译抑制或激活发挥作用。细胞中超过 30%的基因可以直接被 miRs 调控。因此,miRs 被认为是正常发育、生理和发病机制中的重要调控因子。在多种血管疾病中已经揭示了 miR 表达谱的改变。miRs 调节了各种血管疾病中涉及血管生成、新生内膜形成和脂质代谢的血管细胞的多种功能,如细胞分化、收缩、迁移、增殖和炎症。本综述总结了目前关于 miR 在调节动脉粥样硬化和再狭窄中血管细胞功能方面的作用的研究进展和知识。这些发现有望为动脉粥样硬化和再狭窄引起的血管疾病的临床诊断和治疗方法提供机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8417/3438039/e196a132728f/1423-0127-19-79-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8417/3438039/e196a132728f/1423-0127-19-79-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8417/3438039/e196a132728f/1423-0127-19-79-1.jpg

相似文献

1
Roles of microRNAs in atherosclerosis and restenosis.微小 RNA 在动脉粥样硬化和再狭窄中的作用。
J Biomed Sci. 2012 Aug 29;19(1):79. doi: 10.1186/1423-0127-19-79.
2
microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.微小RNA对血管平滑肌细胞和内皮细胞具有独特调控作用:对血管生成、动脉粥样硬化及支架内再狭窄的功能影响
Adv Exp Med Biol. 2015;887:53-77. doi: 10.1007/978-3-319-22380-3_4.
3
MicroRNAs in arterial remodelling, inflammation and atherosclerosis.微小 RNA 在动脉重构、炎症和动脉粥样硬化中的作用。
Curr Drug Targets. 2010 Aug;11(8):950-6. doi: 10.2174/138945010791591377.
4
MicroRNAs in vascular disease.微小 RNA 与血管疾病。
J Cardiovasc Pharmacol. 2011 Jan;57(1):8-12. doi: 10.1097/FJC.0b013e318203759b.
5
Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs.血流敏感型微小RNA在内皮功能障碍和动脉粥样硬化中的作用:机械敏感型动脉粥样硬化微小RNA
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2206-16. doi: 10.1161/ATVBAHA.114.303425. Epub 2014 Jul 10.
6
Mechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.微小RNA在脂质代谢与动脉粥样硬化耦合中的机制作用
Adv Exp Med Biol. 2015;887:79-100. doi: 10.1007/978-3-319-22380-3_5.
7
Therapeutic Potential of Modulating microRNAs in Atherosclerotic Vascular Disease.调节微小RNA在动脉粥样硬化性血管疾病中的治疗潜力
Curr Vasc Pharmacol. 2015;13(3):291-304.
8
MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?miR-296:动脉粥样硬化发病机制中的一个有前途的靶点?
Mol Med. 2018 Mar 26;24(1):12. doi: 10.1186/s10020-018-0012-y.
9
MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis.微小 RNA 调控氧化应激和炎症与肥胖和动脉粥样硬化的关系。
FASEB J. 2011 Aug;25(8):2515-27. doi: 10.1096/fj.11-181149. Epub 2011 Apr 20.
10
The magic and mystery of microRNA-27 in atherosclerosis.miRNA-27 在动脉粥样硬化中的神奇与奥秘
Atherosclerosis. 2012 Jun;222(2):314-23. doi: 10.1016/j.atherosclerosis.2012.01.020. Epub 2012 Jan 18.

引用本文的文献

1
Effect of down-regulation of let-7c/g on triggering a double-negative feedback loop and promoting restenosis.下调 let-7c/g 对触发双负反馈环并促进再狭窄的影响。
Chin Med J (Engl). 2023 Oct 20;136(20):2484-2495. doi: 10.1097/CM9.0000000000002763. Epub 2023 Jul 12.
2
Markers of Restenosis after Percutaneous Transluminal Balloon Angioplasty in Patients with Critical Limb Ischemia.经皮腔内血管成形术治疗严重肢体缺血患者再狭窄的标志物。
Int J Mol Sci. 2023 May 22;24(10):9096. doi: 10.3390/ijms24109096.
3
Expression levels of miR-22, miR-30c, miR-145, and miR-519d and their possible associations with inflammatory markers among patients with coronary artery disease.

本文引用的文献

1
The role of microRNAs in arterial remodelling.microRNAs 在动脉重构中的作用。
Thromb Haemost. 2012 Apr;107(4):611-8. doi: 10.1160/TH11-12-0826. Epub 2012 Feb 28.
2
miR-221 is required for endothelial tip cell behaviors during vascular development.miR-221 对于血管发育过程中内皮细胞尖端细胞行为是必需的。
Dev Cell. 2012 Feb 14;22(2):418-29. doi: 10.1016/j.devcel.2012.01.008.
3
Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?循环 microRNAs:心血管疾病的生物标志物还是介质?
冠心病患者中miR-22、miR-30c、miR-145和miR-519d的表达水平及其与炎症标志物的可能关联。
ARYA Atheroscler. 2022 May;18(3):1-10. doi: 10.48305/arya.v18i0.2436.
4
Myotubularin-Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo-Like Kinase1.肌小管素相关蛋白 14 通过抑制 Polo 样激酶 1 来防止新生内膜形成和血管平滑肌细胞增殖。
J Am Heart Assoc. 2022 Nov;11(21):e026174. doi: 10.1161/JAHA.122.026174. Epub 2022 Oct 31.
5
Dexamethasone suppresses the proliferation and migration of VSMCs by FAK in high glucose conditions.地塞米松通过 FAK 在高糖条件下抑制 VSMCs 的增殖和迁移。
BMC Pharmacol Toxicol. 2022 Aug 17;23(1):63. doi: 10.1186/s40360-022-00604-3.
6
Differential Expression of miRNA-223 in Coronary In-Stent Restenosis.miRNA-223在冠状动脉支架内再狭窄中的差异表达
J Clin Med. 2022 Feb 6;11(3):849. doi: 10.3390/jcm11030849.
7
Statins and Inflammation.他汀类药物与炎症。
Curr Atheroscler Rep. 2021 Dec 1;23(12):80. doi: 10.1007/s11883-021-00977-6.
8
Circulating microRNA-126 as an Independent Risk Predictor of Coronary Artery Disease: A Case-Control Study.循环微小RNA-126作为冠状动脉疾病的独立风险预测指标:一项病例对照研究。
EJIFCC. 2021 Oct 18;32(3):347-362. eCollection 2021 Oct.
9
Adhesion of monocytes and endothelial cells isolated from the human aorta suppresses by miRNA-PEI particles.载 miRNA-PEI 颗粒抑制人主动脉分离的单核细胞和内皮细胞黏附。
BMC Cardiovasc Disord. 2021 Aug 16;21(1):395. doi: 10.1186/s12872-021-02203-2.
10
Association between miR-146a and Tumor Necrosis Factor Alpha (TNF-α) in Stable Coronary Artery Disease.miR-146a 与稳定型冠状动脉疾病肿瘤坏死因子-α(TNF-α)的相关性。
Medicina (Kaunas). 2021 Jun 4;57(6):575. doi: 10.3390/medicina57060575.
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2383-90. doi: 10.1161/ATVBAHA.111.226696.
4
Restenosis after PCI. Part 1: pathophysiology and risk factors.经皮冠状动脉介入治疗(PCI)后的再狭窄。第 1 部分:病理生理学和危险因素。
Nat Rev Cardiol. 2011 Sep 13;9(1):53-62. doi: 10.1038/nrcardio.2011.132.
5
MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo.MicroRNA-133 控制体外血管平滑肌细胞表型转换和体内血管重构。
Circ Res. 2011 Sep 30;109(8):880-93. doi: 10.1161/CIRCRESAHA.111.240150. Epub 2011 Aug 18.
6
miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study.在坦佩雷血管研究中,miR-21、miR-210、miR-34a 和 miR-146a/b 在人动脉粥样硬化斑块中上调。
Atherosclerosis. 2011 Nov;219(1):211-7. doi: 10.1016/j.atherosclerosis.2011.07.020. Epub 2011 Jul 22.
7
The altered expression of inflammation-related microRNAs with microRNA-155 expression correlates with Th17 differentiation in patients with acute coronary syndrome.急性冠状动脉综合征患者中,炎症相关 microRNAs 的表达改变与 Th17 分化相关,其中 microRNA-155 的表达与 Th17 分化相关。
Cell Mol Immunol. 2011 Nov;8(6):486-95. doi: 10.1038/cmi.2011.22. Epub 2011 Aug 1.
8
Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.血流依赖调控的 Kruppel 样因子 2 是由 microRNA-92a 介导的。
Circulation. 2011 Aug 2;124(5):633-41. doi: 10.1161/CIRCULATIONAHA.110.005108. Epub 2011 Jul 18.
9
MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension.微小 RNA-130a 介导高血压中的血管平滑肌细胞增殖。
Am J Hypertens. 2011 Oct;24(10):1087-93. doi: 10.1038/ajh.2011.116. Epub 2011 Jul 14.
10
miR-200a modulate HUVECs viability and migration.miR-200a 调节 HUVECs 的活力和迁移。
IUBMB Life. 2011 Jul;63(7):553-9. doi: 10.1002/iub.486.